Greenwich LifeSciences ( GLSI ) Issues Year End Update
Flamingo - a new breast cancer therapy which has been developed in the US and Europe, is being expanded into Europe. The Steering Committee of Greenwich LifeSciences, Inc. (GLSI) has met with clinicians from around the world.
Source: streetinsider.comPublished on 2022-12-29
Related news
- Smart sex toys : appealing to you , exploitable to hackers
- 2 exciting ASX tech shares that could be buys 21 June 2021
- Technology : a community reunited
- Why predictive analytics will shape the future of every sector
- Greenwich LifeSciences Provides Year End Update
- Commercialising open source
- Logiq Partners with IRIS . TV to Provide Video - Level Data to E - Commerce Marketers and Improve Video Campaign Performance
- Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial
- iTWire - iTWireTV INTERVIEW : Google Cloud Bruno Aziza makes sense of data and analytics in our accelerated times